Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001787306-25-000124
Filing Date
2025-08-06
Accepted
2025-08-06 16:15:00
Documents
68
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arqt-20250630.htm   iXBRL 10-Q 1026274
2 EX-10.1 exhibit101boramanufacturin.htm EX-10.1 319896
3 EX-10.2 exhibit102boraamendmentno1.htm EX-10.2 16236
4 EX-10.3 exhibit103boraamendmentno2.htm EX-10.3 16132
5 EX-31.1 exhibit311ceoq22025.htm EX-31.1 10660
6 EX-31.2 exhibit312cfoq22025.htm EX-31.2 10627
7 EX-32.1 exhibit321ceocfoq22025.htm EX-32.1 6877
  Complete submission text file 0001787306-25-000124.txt   6576884

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20250630.xsd EX-101.SCH 43849
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arqt-20250630_cal.xml EX-101.CAL 63911
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arqt-20250630_def.xml EX-101.DEF 191124
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20250630_lab.xml EX-101.LAB 598449
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20250630_pre.xml EX-101.PRE 402727
71 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20250630_htm.xml XML 827547
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39186 | Film No.: 251189759
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)